XML 83 R66.htm IDEA: XBRL DOCUMENT
v3.21.2

Commitments and Contingencies - Additional Information (Detail) - USD ($) | 12 Months Ended | 24 Months Ended
--- | --- | ---
Sep. 30, 2021 | Sep. 30, 2020 | Sep. 30, 2019 | Sep. 30, 2018 | Sep. 30, 2024
Commitments And Contingencies [Line Items] |  |  |  |  |
Payments to acquire in-process research and development |  |  | $ 750,000 |  |
Acquisition charge for in-process of research and development |  |  | 890,000 |  |
Other long-term liabilities | $ 11,649,000 | $ 8,020,000 |  |  |
Other accrued liabilities current | 407,000 | 278,000 |  |  |
Embolitech LLC [Member] |  |  |  |  |
Commitments And Contingencies [Line Items] |  |  |  |  |
Contingent payments upon achievement of regulatory milestones | $ 1,000,000.0 |  |  |  |
Installment payment beginning period | 2022 |  |  |  |
Installment payment ending period | 2024 |  |  |  |
CRO [Member] |  |  |  |  |
Commitments And Contingencies [Line Items] |  |  |  |  |
Contractual obligation remaining to be paid | $ 7,000,000 |  |  |  |
CRO [Member] | Minimum [Member] |  |  |  |  |
Commitments And Contingencies [Line Items] |  |  |  |  |
Gross contractual obligation | 37,000,000 |  |  |  |
CRO [Member] | Maximum [Member] |  |  |  |  |
Commitments And Contingencies [Line Items] |  |  |  |  |
Gross contractual obligation | 40,000,000 |  |  |  |
CRO [Member] | Maximum [Member] | CRO Pass-through Expenses [Member] |  |  |  |  |
Commitments And Contingencies [Line Items] |  |  |  |  |
Gross contractual obligation | 29,000,000 |  |  |  |
In-Process Research and Development [Member] | Embolitech LLC [Member] |  |  |  |  |
Commitments And Contingencies [Line Items] |  |  |  |  |
Payments to acquire in-process research and development | $ 1,000,000.0 | 1,000,000.0 |  | $ 5,000,000.0 |
Contingency period ending year | 2033 |  |  |  |
Contingent obligation due and payable as a result of achievement of regulatory milestone(s) | $ 1,000,000.0 |  |  |  |
Other long-term liabilities | 6,400,000 | 2,200,000 |  |  |
Other accrued liabilities current |  | $ 1,100,000 |  |  |
In-Process Research and Development [Member] | Embolitech LLC [Member] | Forecast [Member] |  |  |  |  |
Commitments And Contingencies [Line Items] |  |  |  |  |
Contractual obligation payable in fiscal 2022 through fiscal 2024 |  |  |  |  | $ 2,500,000
In-Process Research and Development [Member] | Medical Device [Member] |  |  |  |  |
Commitments And Contingencies [Line Items] |  |  |  |  |
Payments to acquire in-process research and development | $ 200,000 |  | 800,000 |  |
Contingent payments upon achievement of regulatory milestones |  |  | 1,100,000 |  |
Contingency period ending year | 2022 |  |  |  |
Acquisition charge for in-process of research and development |  |  | $ 900,000 |  |

X
- Definition Asset acquisition contingency period ending year. + References No definition available. + Details
Name: | srdx_AssetAcquisitionContingencyPeriodEndingYear
Namespace Prefix: | srdx_
Data Type: | xbrli:gYearItemType
Balance Type: | na
Period Type: | duration

X
- Definition Contingent obligation due and payable as a result of achievement of regulatory milestone(s). + References No definition available. + Details
Name: | srdx_AssetAcquisitionContingentObligationUponAchievementOfRegulatoryMilestones
Namespace Prefix: | srdx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Asset acquisition contingent payments upon achievement of regulatory milestones. + References No definition available. + Details
Name: | srdx_AssetAcquisitionContingentPaymentsUponAchievementOfRegulatoryMilestones
Namespace Prefix: | srdx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Asset acquisition installment payment, beginning period. + References No definition available. + Details
Name: | srdx_AssetAcquisitionInstallmentPaymentBeginningPeriod
Namespace Prefix: | srdx_
Data Type: | xbrli:gYearItemType
Balance Type: | na
Period Type: | duration

X
- Definition Asset acquisition installment payment, ending period. + References No definition available. + Details
Name: | srdx_AssetAcquisitionInstallmentPaymentEndingPeriod
Namespace Prefix: | srdx_
Data Type: | xbrli:gYearItemType
Balance Type: | na
Period Type: | duration

X
- Definition Commitments and contingencies. + References No definition available. + Details
Name: | srdx_CommitmentsAndContingenciesLineItems
Namespace Prefix: | srdx_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Gross amount of contractual obligation, including the portion of the obligation satisfied to date. + References No definition available. + Details
Name: | srdx_GrossContractualObligation
Namespace Prefix: | srdx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Future cash outflow to pay for purchases of fixed assets that have occurred. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586 + Details
Name: | us-gaap_CapitalExpendituresIncurredButNotYetPaid
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments. + References No definition available. + Details
Name: | us-gaap_ContractualObligation
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.20) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 9 -URI http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765 + Details
Name: | us-gaap_OtherAccruedLiabilitiesCurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.24) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_OtherLiabilitiesNoncurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The cash outflows from the purchase of net carrying value allocated to in-process research and development costs and materials acquired in a business combination. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585 + Details
Name: | us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition. + References No definition available. + Details
Name: | us-gaap_ResearchAndDevelopmentInProcess
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | srt_CounterpartyNameAxis=srdx_EmbolitechLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=srdx_ClinicalResearchOrganizationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=srdx_CROPassThroughExpensesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementScenarioAxis=srt_ScenarioForecastMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=srdx_MedicalDeviceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |